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diseases in patients with abnormal glucose tolerance.
Methods: A cross-sectional study in a nationally representative samples of 848 and 849 US adults (aged
≥40 years) with diabetes or prediabetes who had sweet and salt taste disorders, respectively, from the National
Health and Nutrition Examination Survey 2011–2012.
Results: Among the study population, 5.7% had sweet taste disorder and 8.6% had salt taste disorder. These data
correspond to approximately 1.5 million and 1.8 million individuals with abnormal glucose tolerance aged
40 years or older in the US population, respectively. In the adjustedmodel, sweet taste disorderwas signiﬁcantly
associated with complication of ischemic heart disease (adjusted odds ratio [OR], 2.45; 95% conﬁdence interval
[CI], 1.03–5.81; P = 0.04). Moreover, sweet taste disorder in patients with diabetes was signiﬁcantly associated
with diabetic retinopathy (adjusted OR, 2.89; 95% CI, 1.09–7.69; P = 0.03) and diabetic nephropathy (adjusted
OR, 3.17; 95% CI, 1.07–9.36; P = 0.03). Meanwhile, salt taste disorder was not signiﬁcantly associated with dia-
betic retinopathy, diabetic nephropathy, ischemic heart disease, or stroke. Total sugar intake was signiﬁcantly
higher in patients with sweet taste disorder than in those without it, whereas total daily intake of carbohydrate
did not differ signiﬁcantly. No signiﬁcant associationwas observed between salt taste disorder and daily intake of
sodium after multivariate analysis.
Conclusions: Sweet taste disorder in patients with abnormal glucose tolerance was associated with increased
sugar intake and vascular complications.
© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND li-
cense (http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Abnormal glucose tolerance is associated with micro- and macro-
vascular diseases [1–3]. To prevent vascular complications, appropriate
management of atherogenic risk factors such as hyperglycemia and
hypertension is needed [4]. Diet therapy is undoubtedly necessary for
the management of patients with abnormal glucose tolerance [4].S, National Health andNutrition
r ﬁltration rate; NCHS, National
ter; MDRD, Modiﬁcation of Diet
HHS, Department of Health and
ndocrinology, and Metabolism,
d Medicine, 1-21-1 Toyama,
oto).
land Ltd. This is an open access articlPresent recommendations have been clariﬁed to emphasize that pa-
tients with abnormal glucose tolerance should limit or avoid intake of
sugar-sweetened beverages and excess sodium to reduce risk of wors-
ening the cardiometabolic risk proﬁle [4,5]. However, a leading barrier
to diet therapy in patients with abnormal glucose tolerance may be
disorders of tastes such as sweet and salt [6–8]. These taste disorders
can exist comorbidly in patients with diabetes [6,8] and can be seen
earlier than other complications such as diabetic neuropathy [7]. The
disorders of tastes such as sweet and salt in patients with abnormal
glucose tolerance can negatively affect vascular complications; patients
with sweet and salt taste disordersmay bemore likely to consume large
quantities of sugar and sodium, leading to rapid increases in blood
glucose and hypertension. In addition, sweet taste disorder may reﬂect
impairment of the systemic sweet taste receptor, recently found and
reported to be associated with decreased secretion of glucagon-like
peptide 1 (GLP-1) [9] and increased glucose absorption [10]. However,e under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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micro- and macro-vascular diseases in patients with abnormal glucose
tolerance. The aim of this study was to investigate whether sweet
and/or salt taste disorders are associated with micro- and macro-
vascular diseases in patients with abnormal glucose tolerance.
2. Subjects and methods
2.1. Data sources and study population
This study is a cross-sectional study using data from the National
Health and Nutrition Examination Survey (NHANES).Written informed
consent was obtained from all participants. The National Center for
Health Statistics (NCHS) Research Ethics Review Board approved the
NHANES protocols. NHANES is conducted by the NCHS at the Centers
for Disease Control and Prevention. It uses a stratiﬁed, multistage
probability sampling design, which enables samples to represent the
US civilian non-institutionalized population. Data are collected at
homes and mobile examination centers (MECs). Blood specimens
were collected during the MEC examination. Among adults participat-
ing in the NHANES survey during the 2011–2012 period, the unweight-
ed response rate for household interviews was 72.6%; that for MEC
examinationswas 69.5%.We focused on patientswith abnormal glucose
tolerance, which was deﬁned as self-reported diagnosis of prediabetes
or diabetes. Among patients with prediabetes, patients whose glycated
A1c (HbA1c) levels were ≥6.5% in this survey were regarded as having
diabetes. In the analysis associated with sweet taste disorder, we
excluded those with missing information on the sense of sweet taste
(n = 105), which produced a ﬁnal sample of 848 (Fig. 1). Similarly, in
the analysis associatedwith salt taste disorder, 104 patients hadmissing
information on the sense of salt taste, which resulted in a ﬁnal sample of
849. Females who were pregnant at the time of examination were not
included in the study population.
2.2. Sweet and salt taste disorders
We extracted information about sweet and salt taste disorders from
the 2011–2012 NHANES taste questionnaire data. The data contained
the results of interviews with adults aged ≥40 years about the sense of
taste; these interviews were conducted in their homes by interviewersFig. 1. Participantrained to question participants about the sense of taste. We deﬁned
sweet taste disorder as a condition in which the ability to taste sweet-
ness was worse compared with that when the participant was
25 years old. Salt taste disorder was deﬁned in a similar way to sweet
taste disorder.
2.3. Vascular complications
As for the micro- and macro-vascular complications, diagnoses
of diabetic retinopathy, diabetic nephropathy, ischemic heart
disease, and stroke were identiﬁed. Diabetic retinopathy was
conﬁrmed by self-report. Diabetic nephropathy was deﬁned as
diabetes with macroalbuminuria (urine albumin ≥300 mg/g of
creatinine) and an impaired glomerular ﬁltration rate (estimated
GFR b60 mL/min/1.73 m2).[4] The estimated GFR was calculated
using the following Modiﬁcation of Diet in Renal Disease (MDRD)
Study equation: estimated GFR (mL/min/1.73 m2) =
175 × (Scr)−1.154 × (Age)−0.203 × (0.742 for female) × (1.212 for
African American). Serum creatinine, urine albumin, and creati-
nine were measured during the MEC examination in this survey.
Ischemic heart disease was deﬁned as myocardial infarction or
angina pectoris. Ischemic heart disease and stroke were conﬁrmed
by the trained interviewers.
2.4. Food intake
All NHANES participants were eligible for two 24-hour dietary recall
interviews. The dietary intake data are used to estimate the type and
amount of foods and beverages consumed during the 24-h period
prior to the interview and estimate daily total energy and intake of
nutrients and other food components from those foods and beverages.
The ﬁrst dietary recall interview was conducted in person in the MEC
examination, and the second interview was conducted by telephone 3
to 10 days later by trained interviewers; averages of the total nutrient
intakes at the ﬁrst and the second interviews were assumed as the
daily intakes of each participant. For each participant, daily total nutri-
ent intake from food and beverages were calculated on the average at
the ﬁrst and the second interview. The dietary interview component
was conducted as a partnership between the US Department of Agricul-
ture (USDA) and the US Department of Health and Human Servicest ﬂow chart.
Table 1
Characteristics of US adults aged 40 years or older with abnormal glucose tolerance strat-
iﬁed by the presence/absence of sweet taste disorder.a
Characteristics
Sweet taste
disorder (+)
Sweet taste
disorder (−)
P
value
Unweighted sample, no. (%) 48 (5.7%) 800 (94.3%)
Age range (y) 64.6 (10.5) 60.9 (12.6) 0.004
Female sex 69.6% 52.3% 0.04
Race/ethnicity
Non-Hispanic white 66.6% 62.4% 0.66
Non-Hispanic black 19.1% 15.3% 0.50
Mexican American 5.8% 6.9% 0.80
Othersb 8.5% 15.4% 0.27
Body mass index (kg/m2) 30.1 (6.1) 32.8 (8.2) 0.01
Obesity 50.0% 61.0% 0.19
Current smoking 6.1% 14.2% 0.17
Hypertension 74.7% 68.7% 0.55
Hypercholesteremia 78.2% 66.1% 0.15
Diabetes 71.4% 75.0% 0.68
Duration of diabetes (y) ≥ 10 68.1% 45.9% 0.09
HbA1c (%) 6.8 (2.1) 6.9 (1.7) 0.75
Vascular complications
Ischemic heart disease 34.4% 13.4% 0.01
Stroke 9.2% 6.5% 0.55
Diabetic retinopathy 42.4% 13.7% b0.001
Diabetic nephropathy 11.6% 2.4% 0.01
Total daily intakes
Carbohydrate (g) 207.2 (85.5) 228.3 (99.4) 0.25
Sugar (g) 98.1 (47.4) 89.4 (53.3) 0.30
Sugar/carbohydrate ratio 0.47 (0.14) 0.38 (0.13) 0.004
Abbreviation: HbA1c, glycated A1c.
a Data are represented as number, percent, or mean (SD).
b The category includes other Hispanics and other races including multi-racial
participants.
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were imported into Survey Net, a computer-assisted food coding and
data management system developed by USDA. The USDA dietary data
collection instrument, the Automated Multiple-Pass Method (AMPM),
was designed to provide an efﬁcient and accurate means of collecting
intakes for large-scale national surveys.
2.5. Potential confounders
We extracted data on potential confounders including age, sex, race
and ethnicity, obesity, smoking status, duration of diabetes, HbA1c, and
diagnosis of hypertension and hyperlipidemia. For the purpose of
following analyses, age was divided into two groups according to a
cutoff level of 60 years, which approximated the overall mean value
and was associated with altered taste sensation [11]. Race and ethnicity
were classiﬁed into non-Hispanic white, non-Hispanic black, Mexican
American, and others including other Hispanics and multiracial partici-
pants. Obesity was deﬁned as body mass index (BMI, calculated as
weight in kilograms divided by height in meters squared) of 30 kg/m2
or higher, using the measurements at the MEC examination. Duration
of diabetes was divided into two groups, according to a cutoff level of
10 years. HbA1c was derived from the laboratory examination at the
MEC. We deﬁned hypertension and hyperlipidemia as self-reported di-
agnosis of hypertension and hyperlipidemia.
2.6. Statistical analysis
All statistical analyses were conducted using Stata (version 12.1;
StataCorp LP), accounting for the complex survey design. We used an
appropriate weight for each analysis selected based on the variables in
the analysis. Theseweights accounted for unequal probabilities of selec-
tion and nonresponses to make unbiased national estimates. First,
demographic statistics presented as the number (%) and mean with
standard deviation were compared between those with and those
without taste disorders. We repeated analyses for sweet and salt taste
disorders separately. In addition, rate of daily sodium intake of less
than 2.3 g/day, which is recommended by current guidelines [4,5], is
assessed in patients with salt taste disorder. Continuous variables
were compared using t-tests and categorical variables were compared
using chi-square tests.
To assess the association between taste disorders and vascular
complications, multivariate logistic-regression analyses were per-
formed for patients with abnormal glucose tolerance. In addition, we
performed the same analyses restricted to those with diabetes. We
included age, sex, race and ethnicity, obesity, current smoking,
hypertension, hyperlipidemia, and HbA1c level for adjustment.
Duration of diabetes was added for themultivariate analyses in patients
with diabetes. We also performed multiple regression analyses to
evaluate the association between taste disorders and total daily energy
and intakes of carbohydrate, sugar, and sodium. P values b0.05 were
considered statistically signiﬁcant for all tests.
3. Results
Of the populations aged ≥40 years with abnormal glucose tolerance
in this study in theNHANES, 5.7% had sweet taste disorder and 8.6% had
salt taste disorder. These data correspond to approximately 1.5 million
and 1.8 million individuals, respectively with abnormal glucose toler-
ance aged ≥40 years in the US population [12]. The characteristics of
the study populationwith orwithout sweet taste disorder are presented
in Table 1. Among the population, age and proportion of females were
signiﬁcantly higher in patients with sweet taste disorder than in those
without it. BMI was signiﬁcantly lower in patients with sweet taste dis-
order than in those without it. Prevalence of diabetes and HbA1c levels
was not signiﬁcantly different between those with and those without
sweet taste disorder. Ischemic heart disease was more complicated inpatients with sweet taste disorder than in those without it (34.3% vs.
13.4%, P = 0.01). The complication rates of microvascular diseases
were signiﬁcantly higher in patients with sweet taste disorder than in
those without it (42.4% vs. 13.7% for diabetic retinopathy [P b 0.001]
and 11.6% vs. 2.4% for diabetic nephropathy [P = 0.01]), but that of
stroke did not differ signiﬁcantly between the two groups. Total daily
intake of carbohydrate was lower in patients with sweet taste disorder,
whereas that of sugar was higher in patients with sweet taste disorder.
Although these values were not signiﬁcantly different, the ratio of sugar
to carbohydrate was signiﬁcantly higher in patients with sweet taste
disorder than in those without it (0.47 [0.14] vs. 0.38 [0.13], P= 0.004).
The characteristics of the study populationwith or without salt taste
disorder are shown in Table 2. Proportion of females and prevalence of
hypertension were signiﬁcantly higher in patients with salt taste disor-
der than in those without it. The complication rate of diabetic retinopa-
thy was signiﬁcantly higher in patients with salt taste disorder (30.8%
vs. 14.0%, P = 0.02). Although diabetic nephropathy, ischemic heart
disease, and stroke were more complicated in patients with salt taste
disorder than in those without it, the differences were insigniﬁcant.
Total daily intake of sodium was signiﬁcantly lower in patients with
salt taste disorder than in those without it (2.8 [1.3] g vs. 3.4 [1.5] g,
P = 0.001).
Associations between taste disorders and vascular complications are
presented in Table 3. When multivariate logistic-regression analyses
were performed in patients with abnormal glucose tolerance, the
complication of ischemic heart disease was signiﬁcantly associated
with sweet taste disorder (adjusted odds ratio [OR], 2.45; 95%
conﬁdence interval [CI], 1.03–5.81; P = 0.04). Similarly, multivariate
logistic-regression analyses in the diabetic patients revealed that
sweet taste disorder was signiﬁcantly associated with diabetic retinop-
athy (adjusted OR, 2.89; 95% CI, 1.09–7.69; P = 0.03) and diabetic ne-
phropathy (adjusted OR, 3.17; 95% CI, 1.07–9.36; P = 0.03). Although
ischemic heart disease was more complicated in diabetic patients with
sweet taste disorder, no signiﬁcant association was observed. Mean-
while, salt taste disorder was not signiﬁcantly associated with diabetic
Table 2
Characteristics of US adults aged 40 years or older with abnormal glucose tolerance strat-
iﬁed by the presence/absence of salt taste disorder.a
Characteristics Salt taste disorder
(+)
Salt taste disorder
(−)
P value
Unweighted sample, no. (%) 73 (8.6%) 776 (91.4%)
Age range (y) 64.7 (14.4) 60.9 (12.3) 0.07
Female sex 72.6% 52.0% 0.02
Race/ethnicity
Non-Hispanic white 50.8% 63.6% 0.17
Non-Hispanic black 19.1% 15.2% 0.42
Mexican American 10.5% 6.5% 0.21
Othersb 19.6% 14.7% 0.43
Body mass index (kg/m2) 32.7 (9.2) 32.6 (7.8) 0.92
Obesity 60.7% 60.5% 0.97
Current smoking 15.5% 13.6% 0.61
Hypertension 87.3% 67.7% 0.02
Hypercholesteremia 69.4% 66.6% 0.71
Diabetes 81.5% 74.4 0.30
Duration of diabetes (y) ≥ 10 67.2% 45.6% 0.04
HbA1c (%) 7.6 (2.5) 6.9 (1.7) 0.09
Vascular complications
Ischemic heart disease 22.9% 13.9% 0.05
Stroke 7.9% 6.6% 0.63
Diabetic retinopathy 30.8% 14.0% 0.02
Diabetic nephropathy 6.7% 2.6% 0.17
Total daily intakes
Sodium (g) 2.8 (1.3) 3.4 (1.5) 0.001
b2.3 (g)c 36.0% 20.6% 0.04
a Data are represented as number, percent, or mean (SD). HbA1c, glycated A1c.
b The category includes other Hispanics and other races including multiracial
participants.
c The sodium intake of less than 2.3 g/day is recommended by American Diabetes Asso-
ciation. To convert sodium to salt, multiply by 2.54.
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those having abnormal glucose tolerance or for those having diabetes.
We evaluated the association between taste disorders and total daily
intakes of carbohydrate, sugar, and sodium, using multivariate regres-
sion analyses. In both the abnormal glucose tolerance and diabetes
groups, total sugar intake was signiﬁcantly higher in patients with
sweet taste disorder than in thosewithout it (P=0.03 and P=0.01, re-
spectively). Total daily intakes of carbohydrate and sodium did not dif-
fer signiﬁcantly between patients with and without sweet tasteTable 3
Adjusted associations between taste disorders and vascular complications.†
Event Sweet taste disorder Salt taste disorder
Adjusted
OR (95% CI)
P
value
Adjusted
OR (95% CI)
P
value
Participants with abnormal glucose
tolerance††
Ischemic heart disease 2.96
(1.07–8.19)
0.03 1.54
(0.69–3.42)
0.26
Stroke 0.80
(0.20–3.18)
0.74 0.70
(0.18–2.61)
0.57
Participants with diabetes
Diabetic retinopathy 2.89
(1.09–7.69)
0.03 2.50
(0.89–7.04)
0.07
Diabetic nephropathy 3.17
(1.07–9.36)
0.03 1.51
(0.56–4.05)
0.38
Ischemic heart disease 2.23
(0.66–7.56)
0.18 1.33
(0.65–2.72)
0.41
Stroke 0.78
(0.21–2.83)
0.69 0.69
(0.17–2.82)
0.59
Abbreviations: OR, odds ratio; CI, conﬁdence interval.
Bold type indicates a signiﬁcant association (P b 0.05).
† Odds ratio was adjusted for age, sex, race and ethnicity, obesity, current smoking,
hypertension, hyperlipidemia, and HbA1c level in patients with abnormal glucose toler-
ance. Duration of diabetes was added for the adjustment in patients with diabetes.
†† Abnormal glucose tolerance included prediabetes and diabetes.disorder. No signiﬁcant associationwas observed between salt taste dis-
order and intakes of carbohydrate, sugar, and sodium.
4. Discussion
To our knowledge, this is the ﬁrst large-scale study to report that
sweet taste disorder in patientswith abnormal glucose tolerance anddi-
abetes is associated with vascular complications. In addition, this study
revealed that daily sugar intake is signiﬁcantly higher in patients with
sweet taste disorder than in those without it, even though the total car-
bohydrate intake did not show signiﬁcant differences. On the other
hand, an association between salt taste disorder and vascular complica-
tions was not observed, and daily intake, including sodium, was not
signiﬁcantly different.
Taste disorders can be a complication in patients with abnormal glu-
cose tolerance [6–8]. In particular, sweet taste disordermay be a notable
complication in patients with abnormal glucose tolerance. Sweet taste
disorder in patients with abnormal glucose tolerance was associated
with increased sugar intake. Large quantities of sugar can contribute
to risk of vascular damage, partly by their ability to contribute to obesity,
but an independent effect may also stem from the high amounts of rap-
idly absorbable carbohydrates [13–15]. Excess consumption of sugar
has been shown to result in rapid and dramatic increases in blood
glucose and insulin concentrations [13]. A large and growing body of
evidence shows that postprandial hyperglycemia is associated with
microvascular diseases [16,17], cardiovascular disease [18,19], and
mortality [20]. Moreover, recent studies suggest that postprandial
hyperglycemia is also linked to cognitive dysfunction in elderly people
[21], and certain cancers [22]. According to the results of many
fundamental studies, themain mechanism through which acute hyper-
glycemia exerts harmful effects on diabetic complications may be
identiﬁed in the production of free radicals [18]. Because signiﬁcant
evidence has demonstrated the harmful effects of postprandial hyper-
glycemia, special attention should be paid to patients with sweet taste
disorder. Meanwhile, salt taste disorder was not associated with
vascular complications or daily intake of sodium in the multivariate
analyses. Patients with abnormal glucose tolerance may adequately
regulate daily sodium intake independently of salt taste disorder.
The sensitivity of taste in patients with abnormal glucose tolerance
can be inﬂuenced not only by aging and smoking [11,23] but also the
complication of diabetic neuropathy [24]. However, a previous study
reported that patients with newly-diagnosed diabetes, who had no
clinical evidence of diabetes-related complications, also showed
impaired taste [7]. In addition, a direct effect of blood glucose concentra-
tion on taste may be unlikely [25]. Therefore, the opposite causal path
may be more plausible; inherent or acquired impairment of the taste
receptor may lead to taste disorder. The receptors of basic ﬁve
tastes—sweet, salt, bitter, sour, and umami, are mediated by separate
populations of selectively tuned taste receptor cells [26–28]. Important-
ly, recent studies revealed that cells with taste receptors were not
restricted to the taste buds of the tongue and these receptors elaborate-
ly control the intake and absorption to maintain homeostasis [29,30].
The sweet taste receptor, T1R2/T1R3, is also found in the intestine.
Some studies suggested that sweet taste receptors on L-type
enteroendocrine cells in the intestine are linked to glucagon-like
peptide 1 (GLP-1) secretion,which in turn stimulates insulin production
[9]. In addition, a recent study reported that the dysregulation of
intestinal sweet taste receptors may enhance glucose absorption and
exacerbate postprandial hyperglycemia in patients with type 2 diabetes
[10]. Therefore, if sweet taste disorders in patients with abnormal glu-
cose tolerance reﬂect the systemic impairment of sweet taste receptors,
postprandial hyperglycemia may not stem solely from sugar intake. In
particular, those with sweet taste disorder in this study might actually
have impaired sweet taste receptors in both the tongue and intestine.
As a result, increased sugar intake, reduced secretion of GLP-1, and
enhanced absorption of glucose might lead to greater ﬂuctuations in
641T. Tsujimoto et al. / International Journal of Cardiology 221 (2016) 637–641blood glucose and increased vascular complications. Further studies are
needed to reveal the association between sweet taste disorder and vas-
cular complications.
This study has several limitations. First, the present study investigat-
ed self-reported disorders of taste that were evaluated by comparison
with the participants' ability to taste at 25 years old. More objective
examinations for the ability to tastemay be needed to reveal the associ-
ation between taste disorders and vascular complications. However, be-
cause established methods to assess taste disorders are lacking in daily
clinical settings, the evaluation method of taste sensation in this study
may be a realistic option for risk assessment of vascular complications.
Second, the cross-sectional nature of the NHANES precludes us from
drawing ﬁrm conclusions, regarding the association between taste dis-
orders and vascular complications. Therefore, some prospective, large-
scale,multicenter studieswill be required to conﬁrmour results. Finally,
the numbers of patients with taste disorders were small, which could
inﬂuence multivariate analyses. However, this study was performed
based on the national survey of US adults and several studies have sup-
ported our results. Therefore, we believe that our study provides ex-
tremely important and novel information about the association
between sweet taste disorder and vascular complications in patients
with abnormal glucose tolerance.
In conclusion, sweet taste disorder in patients with abnormal
glucose tolerancewas associatedwith increased sugar intake and vascu-
lar complications, whereas salt taste disorder was not associated with
daily sodium intake and vascular complications. Further investigation
about sweet taste disorder may lead to better medical care for patients
with abnormal glucose tolerance.
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